Alpha memo: skeletal / muscle mechanism to human failure

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Articulate one bounded, falsifiable research signal: e.g., 'resveratrol's exercise-synergistic benefit observed in rat skeletal/cardiac muscle does not extend to metabolic or inflammatory outcomes in aged human skeletal muscle at 250 mg/day over 8 weeks.'
2. Compare the two studies on the dimensions where they differ (species, dose, duration, primary outcome, population health status) and identify which dimension(s) most plausibly explain the translation failure.
3. Remove or explain the metadata-laden framing language ('geometry', 'shards', 'partial') and replace with content-grounded reasoning.
4. Replace generic falsifier checklist with study-specific conditions for when the apparent reversal would be overturned.
5. Add a limitations subsection noting that Receipt 1's title does not specify dose/duration, so the human-rat comparison is bounded by what can be inferred from titles alone.

Major issues

• The memo frames itself as a bounded 'mechanism_to_human_failure' signal but does not actually integrate the two receipts into an argument — it merely juxtaposes them with no explanation of why the animal benefit failed to translate to aged men (dose, species, duration, metabolic baseline, or outcome mismatch).
• The abstract/one-sentence alpha conflates a discovery statement ('made us expect...') with an update ('forces the update') without clearly stating what the bounded research signal is. A reader cannot extract a single falsifiable claim.
• Receipt 1 (rat study) and Receipt 2 (aged human RCT) differ on species, dose (not specified for rats in title), duration, and primary outcome (performance vs. metabolic/inflammatory biomarkers). Without articulating this mismatch, the 'mechanism_to_human_failure' framing is asserted rather than demonstrated.
• The 'Why this is surprising' section uses abstract metadata language ('geometry', 'shards', 'partial') rather than substantive reasoning grounded in the cited evidence.

Minor issues

• No explicit statement of why resveratrol specifically failed in humans — mechanistic candidates (bioavailability, SIRT1 pathway differences, short 8-week window, healthy rather than compromised baseline) are not raised.
• The caveats/falsifiers are generic checklist items rather than study-specific falsification conditions.
• No mention of whether Receipt 2's exercise-alone benefit is itself a positive signal worth separating from the resveratrol null.
• Receipt 1 has no abstract/excerpt to verify that the rat study actually tested resveratrol effects comparable to the 250 mg human dose.

Reviewer note

The memo identifies a real and potentially interesting cross-species contrast — a rat study showing resveratrol + exercise improves muscle/cardiac outcomes and an aged-human RCT showing exercise alone, but not resveratrol, improves muscle metabolic/inflammatory markers. The two receipts are well-matched on the resveratrol + exercise anchor, which is the core requirement. However, the memo fails to do the analytic work of explaining *why* the signal failed to translate, which is the entire point of a 'mechanism_to_human_failure' framing. The abstract is a discovery+update narration rather than a bounded claim. The 'Why this is surprising' section reads as internal pipeline language, not scientific reasoning. With bounded edits — a clear one-sentence signal, an explicit species/dose/outcome comparison, and study-specific falsifiers — this becomes acceptable. In current form it is a receipt pair in search of an argument.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis